Literature DB >> 2424934

Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.

R N Poston, Y S Sidhu.   

Abstract

Tumours of uncertain tissue of origin were investigated by immunohistochemistry on formalin fixed paraffin embedded sections. Two antibodies--PD7/26, an anti common leucocyte antigen, and CAM5.2, an anticytokeratin--recognised most lymphomas and carcinomas, respectively: 88% of these tumours were identified by the two antibodies alone. These antibodies permitted the separation of the cases into groups: positive with CAM5.2, positive with PD7/26, and a third comprising those negative with both. The negative group contained other tumours and a small number of carcinomas and lymphomas; many of the lymphomas were, apparently, of histiocytic origin. Comparison of CAM5.2 with other epithelial markers showed that it was the most effective. Some further classification of the tumours was carried out with a panel of organ and cell specific antibodies: mesotheliomas were recognised by their pattern of reactivity with epithelial markers. Overall, the tumour type was determined in 90% of cases. Immunohistochemistry performed as described can be a potent aid to the diagnostic histopathology of tumours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424934      PMCID: PMC499913          DOI: 10.1136/jcp.39.5.514

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

2.  Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis.

Authors:  H Stein; B Uchánska-Ziegler; J Gerdes; A Ziegler; P Wernet
Journal:  Int J Cancer       Date:  1982-03-15       Impact factor: 7.396

3.  Malignant histiocytosis and Letterer-Siwe disease. Neoplasms of T-zone histiocyte with S100 protein.

Authors:  S Watanabe; T Nakajima; Y Shimosato; Y Sato; K Shimizu
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

4.  Macrophage origin of Reed-Sternberg cells: an immunohistochemical study.

Authors:  S V Payne; D H Wright; K J Jones; M A Judd
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

5.  Malignant histiocytosis of the intestine: a T-cell lymphoma.

Authors:  P G Isaacson; N T O'Connor; J Spencer; D H Bevan; C E Connolly; N Kirkham; D J Pollock; J S Wainscoat; H Stein; D Y Mason
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

6.  Human complement (C3b) receptors defined by a mouse monoclonal antibody.

Authors:  J Gerdes; M Naiem; D Y Mason; H Stein
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

7.  Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.

Authors:  M Nadji; S Z Tabei; A Castro; T M Chu; G P Murphy; M C Wang; A R Morales
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

8.  Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.

Authors:  J M Corson; G S Pinkus
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

9.  Malignant lymphoma of true histiocytic (monocyte/macrophage) origin.

Authors:  P Isaacson; D H Wright; D B Jones
Journal:  Cancer       Date:  1983-01-01       Impact factor: 6.860

10.  Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions.

Authors:  M Nap; K A ten Hoor; G J Fleuren
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

View more
  5 in total

1.  Hodgkin's disease: an immunohistochemical study on paraffin sections. Possible diagnostic usefulness of Leu M1 and common leucocyte antigen staining pattern.

Authors:  J O'Connell; B Tobin; M Kennedy; P A Dervan
Journal:  Ir J Med Sci       Date:  1988-04       Impact factor: 1.568

2.  A monoclonal antibody specific for cells of the melanocyte lineage.

Authors:  C Vennegoor; P Hageman; H Van Nouhuijs; D J Ruiter; J Calafat; P J Ringens; P Rümke
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.

Authors:  Luis I Pozos-Ochoa; Leonardo S Lino-Silva; Alberto M León-Takahashi; Rosa A Salcedo-Hernández
Journal:  Pathol Oncol Res       Date:  2017-08-07       Impact factor: 3.201

4.  Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues.

Authors:  M J Goddard; B Wilson; J W Grant
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

5.  Primary colonic signet ring cell carcinoma presenting carcinocythemia: an autopsy case.

Authors:  Ryosuke Misawa; Motohiro Kobayashi; Makoto Ito; Mai Kato; Yuji Uchikawa; Satoshi Takagi
Journal:  Case Rep Gastroenterol       Date:  2008-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.